When a couple is struggling to conceive – or experiencing recurrent miscarriages sperm DNA fragmentation is increasingly recognised as a critical factor that standard semen analysis simply cannot detect. Yet when men are advised to get a sperm DNA fragmentation test, many are confronted with an unfamiliar choice: SCSA®, TUNEL or SCD. Each test measures DNA damage in sperm, but they do so in fundamentally different ways and the results can vary considerably between methods.
This guide explains exactly what each test measures, how they differ, which clinical situations call for which method and how to make the right decision for your specific fertility circumstances.
Why Sperm DNA Fragmentation Matters
A semen analysis tells you about sperm count, motility and morphology – but it says nothing about the genetic integrity of the DNA packed inside each sperm cell. A man can have a completely normal semen analysis and still have high levels of DNA fragmentation, meaning his sperm carry damaged genetic material that can impair fertilisation, embryo development and implantation.
Studies consistently show that high sperm DNA fragmentation is linked to:
- Recurrent miscarriage (two or more pregnancy losses)
- Failed IVF or IUI cycles despite good embryo quality
- Unexplained male infertility
- Poor embryo development post-fertilisation.
The DNA Fragmentation Index (DFI) is the key metric – a DFI above 25–30% is generally considered clinically significant, though interpretation depends on the testing method used.
Understanding the Three Main Tests
The SCSA® (Sperm Chromatin Structure Assay)
The SCSA® is widely considered the gold standard for sperm DNA fragmentation testing. Developed in the 1980s and extensively validated in peer-reviewed literature, it uses flow cytometry to measure sperm DNA fragmentation. It uses acid denaturation followed by staining with Acridine Orange to identify existing DNA strand breaks. Intact double stranded DNA fluoresce green while damaged single stranded DNA fluoresce red.
The test measures two values: the DFI (DNA Fragmentation Index) and the High DNA Stainability (HDS) value. HDS reflects the proportion of immature sperm with poorly compacted chromatin – another marker associated with poor fertility outcomes.
Key advantages of SCSA®:
- Highly standardised with decades of published reference data
- Measures both DFI and chromatin immaturity simultaneously
- Excellent reproducibility between laboratories
- Specific DFI thresholds are well-established for natural conception, IUI and IVF/ICSI outcomes.
The SCSA® is particularly well-suited for couples pursuing IUI, natural conception or for men who want the most clinically validated assessment available. It is the test with the largest body of longitudinal outcome data.
The TUNEL Assay (Terminal deoxynucleotidyl transferase dUTP Nick End Labelling)
The TUNEL assay detects DNA strand breaks by labelling the ends of broken DNA strands with a fluorescent marker. TUNEL identifies existing single- and double-strand breaks in sperm DNA.
The test can be performed using flow cytometry or fluorescence microscopy, and the latter allows individual sperm to be visually assessed, which has specific advantages in certain clinical contexts.
Key advantages of TUNEL:
- Highly sensitive, especially for double-strand breaks
- Useful in IVF/ICSI settings where sperm selection is possible
- Can be performed on small sperm samples, including testicular sperm (TESA/TESE).
TUNEL is particularly useful when IVF or ICSI is already planned, or when clinicians want to assess surgically retrieved sperm for DNA quality before using them in treatment. Its sensitivity makes it valuable in complex cases.
The SCD Test (Sperm Chromatin Dispersion)
The SCD test – also marketed commercially as the Halosperm® test – is a simpler, more accessible method that assesses DNA fragmentation based on how sperm nuclei disperse chromatin after acid denaturation. Sperm with intact DNA form a large halo of dispersed chromatin; sperm with fragmented DNA produce a small or absent halo.
Unlike SCSA® and TUNEL, the SCD test is typically performed using light microscopy and does not require flow cytometry, making it more widely available and cost-effective.
Key advantages of SCD:
- Lower cost and more widely available
- Does not require specialised flow cytometry equipment
- Straightforward visual interpretation
- Suitable for initial screening in resource-limited settings.
The limitation of SCD is that it is generally considered less precise than SCSA® or TUNEL, with greater variability between laboratories and observers. It serves as a useful screening tool, but when clinical decisions depend on exact DFI values, a more rigorous method is preferable.
Comparing the Three Tests: A Summary
Which Test Should You Choose?
The choice of sperm DNA fragmentation test should be guided by your clinical situation, but it is also important to consider the reliability and standardisation of the test being used.
SCSA® (Sperm Chromatin Structure Assay) is widely regarded as the most standardised and reproducible method. It has been extensively validated over decades, with clearly established reference ranges and strong clinical correlations with fertility outcomes. Because of this high level of standardisation, results are consistent across laboratories and can be confidently interpreted by fertility specialists.
TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labelling) is also a useful test, particularly in assisted reproduction settings, as it directly detects DNA strand breaks. However, its methodology can vary between laboratories, which may affect consistency and comparability of results.
SCD (Sperm Chromatin Dispersion) is often used as a simpler and more accessible option. While it can provide an initial assessment, it is less standardised and may show variability in interpretation. In some cases, further confirmation with a more validated test may be advised.
Interpreting Your Results
Regardless of the method used, the DFI is the central value to understand:
- Below 15%: Low fragmentation; associated with good fertility outcomes
- 15–25%: Moderate fragmentation; natural conception still possible but assisted methods may be considered
- Above 25–30%: High fragmentation; associated with significantly reduced natural conception rates and poorer IVF outcomes
- Above 50%: Very high fragmentation; specialist intervention typically required.
It is important to note that DFI thresholds are not absolute – they must be interpreted alongside the couple’s full clinical history, the woman’s fertility status and the specific treatment being planned.
What Comes Next After a High DFI Result?
A high DFI result is not the end of the road. There are well-established strategies to reduce DNA fragmentation before treatment, including:
- Identifying and addressing lifestyle factors (smoking, heat exposure, obesity, oxidative stress)
- Antioxidant supplementation protocols
- Treating underlying infections or varicocele
- In IVF settings, using techniques such as PICSI or magnetic-activated cell sorting (MACS) to select sperm with intact DNA
- Considering testicular sperm extraction (TESE) in severe cases, as testicular sperm tend to have lower fragmentation than ejaculated sperm.
Getting Tested at Andrology Center
Andrology Center offers SCSA®-based sperm DNA fragmentation testing alongside a full range of male fertility assessments, including semen analysis, hormone panels and advanced diagnostic tests. With standardised reports and accurate results, fertility specialists can decide on the best treatment method.
If you have experienced recurrent pregnancy loss, failed IVF cycles or simply want to understand your fertility status fully before starting treatment, a sperm DNA fragmentation test is a valuable step – and choosing the right method ensures that the results genuinely guide your care.
